Ulanzi Unveils Move LightGo: High-Precision Remote Lighting Control, Scene Memory & Multi-Unit Sync for Enhanced Shooting Efficiency HONG KONG, Nov. 18, 2025 /PRNewswire/ — Ulanzi, a leading innovator in photography… CISION PRNewswireNovember 17, 2025
Press Release ABOK Delivers Reliable, Sustainable Power With Its Ark Series — Now Available at Exclusive Black Friday Savings MIAMI, Nov. 17, 2025 /PRNewswire/ — ABOK, an emerging innovator in portable… CISION PRNewswireNovember 17, 2025
Canary Speech Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Technology Innovation Leadership Recognized for transforming Intelligent Vocal Biomarker Diagnostics through innovative AI-powered, smartphone-based diagnostic… CISION PRNewswireNovember 17, 2025
Press Release SwitchBot Launches the New Presence Sensor with mmWave Radar TOKYO, Nov. 17, 2025 /PRNewswire/ — SwitchBot, a leading provider of AI-enabled embodied… CISION PRNewswireNovember 17, 2025
Ajinomoto Bio-Pharma Services Wins "Best ADC Preclinical Publication 2024" Award for AJICAP® Technology at 2025 World ADC Awards Recognition underscores Ajinomoto Bio-Pharma Services’ innovation and scientific excellence in advancing next-generation… CISION PRNewswireNovember 17, 2025
Business Press Release EICMA 2025: A RECORD-BREAKING EDITION, COMBINING PASSION, BUSINESS, NEW CONTENT, AND NEW WAYS TO GET TO THE SHOW The 82nd International Two-Wheeler Exhibition closes with more than 600,000 visitors. Growth… CISION PRNewswireNovember 17, 2025
Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs BOSTON, Nov. 17, 2025 /PRNewswire/ — Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage… CISION PRNewswireNovember 17, 2025
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US SHANGHAI and JERSEY CITY, N.J., Nov. 17, 2025 /PRNewswire/ — Shanghai Henlius Biotech,… CISION PRNewswireNovember 17, 2025
